Back to the feed
In brief
On 11.10.2023, a person holding the function "Executive member of the board of directors / senior management" at PolyPeptide Group AG disclosed a purchase worth CHF 2’876’349 to SIX Exchange Regulation.
This is the largest management purchase disclosed at PolyPeptide Group AG over the previous 12 months (2 purchases in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of PolyPeptide Group AG declared a "Purchase" transaction on 11.10.2023.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date11.10.2023
Issuing companyPolyPeptide Group AG
ISINCH1110760852
Transaction sidePurchase
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity159’959
Unit priceCHF 17.98
AmountCHF 2’876’349
ExchangeXSWX
Notification IDT1NAB00037
Other PolyPeptide Group AG insider transactions
- Sale · Executive member of the board of directors / senior management30.10.2026CHF 10’095’679
- Sale · Executive member of the board of directors / senior management30.10.2026CHF 6’321’929
- Sale · Non-executive member of the board of directors30.10.2026CHF 2’008’085
- Sale · Non-executive member of the board of directors30.10.2026CHF 1’453’944
- Sale · Non-executive member of the board of directors30.10.2026CHF 1’316’096
These figures aggregate public disclosures. They are not investment advice.